Archive: September 2023
Feature Article
Selecting the Optimal Radiation Modality in Prostate Cancer
Abstract: There are numerous radiation modalities for the definitive treatment of localized prostate cancer. Classic clinical trials have established the basic tenets of treatment approaches, and […]
Feature Article
Predicting Outcomes and Monitoring Disease in Patients With Multiple Myeloma
Abstract: Multiple myeloma (MM) is a clonal plasma cell dyscrasia and the most common form of primary bone marrow cancer. Nearly 35,000 new cases of MM […]
Hem/Onc News
Hem/Onc News
Melphalan Approved as Liver-Directed Treatment for Uveal Melanoma On August 14, the US Food and Drug Administration (FDA) approved the use of the melphalan hepatic delivery […]
Advances in Hematology
Principles of Gene Therapy for the Hematologist
H&O What is the definition of gene therapy? JS The most basic definition of gene therapy is the use of genes to prevent or treat disease. […]
Letter From the Editor
From the Mundane to the Absurd
My family was downsizing our belongings, so I went to the Spectrum store to return a cable modem, cable box, and router that we no longer […]
Advances in Drug Development
Repurposing Drugs in Oncology
H&O What is drug repurposing, and how is it used in oncology? EV Drug repurposing describes the phenomenon of using drugs that are already approved or […]
Breast Cancer In Focus
Expanding the Use of PARP Inhibitors in Breast Cancer
H&O Which patients with breast cancer are currently eligible for poly(ADP-ribose) polymerase (PARP) inhibition? TT For this question, I refer to the National Comprehensive Cancer Network […]